Summary:
«EureKARE has raised a $60 million series A round to fund the creation and advancement of synthetic biology and microbiome startups. The cash will enable eureKARE to build companies around science at European labs, bridging a perceived gap in the biopharma environment.»
Article written by Nick Paul Taylor
17|05|2021
Source:
Fierce Biotech
https://www.fiercebiotech.com/biotech/eurekare-raises-60m-to-create-eu-synbio-and-microbiome-startups